Highly Persistent and Effective Prime/Boost Regimens Against Tuberculosis That Use a Multivalent Modified Vaccine Virus Ankara-Based Tuberculosis Vaccine With Interleukin-15 as a Molecular Adjuvant
Clinical and Vaccine Immunology- United States
doi 10.1128/cvi.00006-10
Full Text
Abstract
Available in
Date
March 31, 2010
Authors
Publisher
American Society for Microbiology